Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLXN

Silexion Therapeutics Corp

May 22 • 04:00PM ET

0.5000

+0.0250 5.26 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: LIXT TNXP PALI SABS BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-9.46	Insider Own	7.13%	Shs Outstand	4.19M	Perf Week	73.01%
Market Cap	2.09M	Forward P/E	-	EPS next Y	-2.23	Insider Trans	-7.11%	Shs Float	3.89M	Perf Month	-45.66%
Enterprise Value	1.64M	PEG	-	EPS next Q	-1.31	Inst Own	1.60%	Short Float	0.85%	Perf Quarter	-64.79%
Income	-12.91M	P/S	-	EPS this Y	54.02%	Inst Trans	0.48%	Short Ratio	0.01	Perf Half Y	-79.76%
Sales	0.00M	P/B	5.37	EPS next Y	45.87%	ROA	-200.00%	Short Interest	0.03M	Perf YTD	-73.96%
Book/sh	0.09	P/C	0.86	EPS next 5Y	33.21%	ROE	-897.46%	52W High	22.36 -97.76%	Perf Year	-96.62%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	- -38.17%	ROIC	-2381.92%	52W Low	0.23 116.45%	Perf 3Y	-99.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	29.16% 21.48%	Perf 5Y	-99.96%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	96.81%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.00	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.06	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.00	EPS Q/Q	77.96%	SMA20	-5.04%	Beta	-0.31	Target Price	6.00
Payout	-	Debt/Eq	6.86	Sales Q/Q	-	SMA50	-46.02%	Rel Volume	0.48	Prev Close	0.47
Employees	14	LT Debt/Eq	0.86	Earnings	May 18 BMO	SMA200	-81.84%	Avg Volume	5.50M	Price	0.50
IPO	Apr 07, 2021	Option/Short	No / No	EPS/Sales Surpr.	34.11% -	Trades		Volume	2,614,000	Change	5.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)